# Aragen Life Sciences IPO Plans $160.5m Expansion

> Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.
- Title: Aragen Life Sciences IPO Plans $160.5m Expansion | Shortify
- Summary: Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.
- Keywords: aragen life sciences, ipo, drug development, manufacturing business, contract research, imrac, syngene, biologics manufacturing, small molecules, The Economic Times
- URL: https://shortify.news/The_Economic_Times/aragen-life-sciences-ipo-plans-1605m-expansion
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/ipo-bound-aragen-plans-to-spend-rs-15-billion-over-3-years-for-expansion-md-says/articleshow/135956847.cms
- Author: Reuters
- Published: 2026-11-18T08:58:00+00:00
- Read time: 1 min
- Topics: aragen life sciences, ipo, drug development, manufacturing business, contract research, imrac, syngene, biologics manufacturing, small molecules
## IPO-bound Aragen expansion plans
Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.
## Investment breakdown
Rs 10 billion for contract development and Rs 4 billion for discovery research.
## Capacity expansion targets
Small molecules capacity to 650 kilolitres; biologics to 8.5 kilolitres by next year.
## Key takeaway

Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO.

---

Summary: Shortify — https://shortify.news/The_Economic_Times/aragen-life-sciences-ipo-plans-1605m-expansion
Reporting: The Economic Times — https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/ipo-bound-aragen-plans-to-spend-rs-15-billion-over-3-years-for-expansion-md-says/articleshow/135956847.cms

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.